Archive
Year
Volume(Issue)
Issues
Journal Article
Download
فارسی Version
The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Year:
Volume:
Issue:
Pages:
Citations:
Views:
Downloads:
more
View 74
A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence
View 106
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
View 77
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges
View 120
Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges
View 66
Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?
View 71